ArTS Archivio della ricerca di Trieste

PACOR, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.695
EU - Europa 7.542
AS - Asia 5.533
SA - Sud America 634
AF - Africa 173
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
Totale 25.606
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.540
SG - Singapore 2.062
PL - Polonia 1.835
CN - Cina 1.453
SE - Svezia 974
DE - Germania 951
IT - Italia 931
UA - Ucraina 714
VN - Vietnam 559
BR - Brasile 501
HK - Hong Kong 488
RU - Federazione Russa 404
GB - Regno Unito 371
FR - Francia 330
KR - Corea 327
FI - Finlandia 322
TR - Turchia 237
NL - Olanda 149
BG - Bulgaria 125
IE - Irlanda 124
IN - India 96
CA - Canada 75
CH - Svizzera 54
MA - Marocco 54
BE - Belgio 53
MX - Messico 48
AR - Argentina 47
BY - Bielorussia 43
JP - Giappone 42
ZA - Sudafrica 38
ES - Italia 34
BD - Bangladesh 33
IQ - Iraq 32
AT - Austria 26
PK - Pakistan 26
ID - Indonesia 21
UZ - Uzbekistan 19
VE - Venezuela 19
KE - Kenya 18
SN - Senegal 18
PH - Filippine 17
EC - Ecuador 15
RO - Romania 15
CO - Colombia 14
AU - Australia 13
BA - Bosnia-Erzegovina 13
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
CL - Cile 11
PE - Perù 11
TH - Thailandia 11
EG - Egitto 10
JO - Giordania 10
LT - Lituania 10
PT - Portogallo 10
HR - Croazia 9
MY - Malesia 9
EU - Europa 8
IL - Israele 8
IR - Iran 8
KZ - Kazakistan 8
RS - Serbia 8
SA - Arabia Saudita 8
PY - Paraguay 7
OM - Oman 6
UY - Uruguay 6
DZ - Algeria 5
GA - Gabon 5
HN - Honduras 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
GR - Grecia 3
HU - Ungheria 3
LV - Lettonia 3
NO - Norvegia 3
PR - Porto Rico 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
DM - Dominica 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
MN - Mongolia 2
Totale 25.577
Salva come PNG Salva come JPEG
Città #
Warsaw 1.693
Singapore 1.242
Ann Arbor 1.188
Woodbridge 1.067
Ashburn 1.051
Houston 862
Fairfield 856
Chandler 700
Jacksonville 618
San Jose 545
Hong Kong 477
Wilmington 458
Dallas 445
Hefei 424
Seattle 364
Beijing 344
Seoul 322
Trieste 313
Cambridge 281
Princeton 229
Boardman 226
Izmir 194
Chicago 172
Ho Chi Minh City 162
Los Angeles 147
Columbus 133
Hanoi 130
Sofia 125
Dublin 122
Lauterbourg 121
Dearborn 120
Zgierz 116
The Dalles 112
Moscow 107
Helsinki 91
Santa Clara 87
Buffalo 81
Frankfurt am Main 81
London 72
Düsseldorf 69
Milan 60
San Diego 57
Munich 56
Council Bluffs 55
Amsterdam 51
New York 50
São Paulo 49
Brussels 48
Casablanca 44
Guangzhou 39
Bern 37
Tokyo 35
Porto Alegre 34
Falls Church 33
Orem 33
Shanghai 32
Phoenix 30
North Bergen 29
Da Nang 28
Brooklyn 27
Bremen 25
Haiphong 25
Mestre 25
Redwood City 25
Stockholm 23
Atlanta 21
Denver 21
Des Moines 21
Norwalk 21
Rio de Janeiro 21
Tianjin 21
Turku 21
Verona 21
Kunming 20
Nanjing 20
Nuremberg 20
Johannesburg 19
Dakar 18
Dong Ket 18
Montreal 18
Sacile 17
Tashkent 17
Vienna 17
Grafing 16
Jinan 16
Toronto 16
Mexico City 15
Nairobi 15
Ottawa 15
Rome 15
Wroclaw 15
Chennai 14
Redmond 14
Redondo Beach 14
Roubaix 14
Washington 14
Baghdad 13
Mumbai 13
Paris 13
Sarajevo 13
Totale 17.494
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines 612
Arabica coffee extract shows antibacterial activity against Staphylococcus epidermidis and Enterococcus faecalis and low toxicity towards a human cell line 517
Biofilms from Klebsiella pneumoniae: Matrix Polysaccharide Structure and Interactions with Antimicrobial Peptides 509
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 470
Effects of gold nanoparticles, protected by self-assembling mixtures of ligands, on eukaryotic cells and model membranes 455
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine 402
HIV Protease Inhibitors Apoptotic Effect in SH-SY5Y Neuronal Cell Line 395
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 378
Insights on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 368
Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives 365
Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing 338
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 310
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. 301
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. 290
The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator 287
Mixed Fluorinated/Hydrogenated Self-Assembled Monolayer-Protected Gold Nanoparticles: In Silico and In Vitro Behavior 283
Apoptotic pathways of U937 leukemic monocytes investigated by infrared microspectroscopy and flow cytometry 275
Antifungal Activity of Amphotericin BConjugated to Carbon Nanotubes 263
Dual mode of action of Bac7, a proline-rich antibacterial peptide 240
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 239
Optimization of microfluidic systems for IRMS long term measurement of living cells 238
Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37 238
Primate beta-defensins--structure, function and evolution. 235
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 235
Infrared microspectroscopy of live cells in microfluidic devices (MD-IRMS): Toward a powerful label-free cell-based assay 235
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 235
Cellular Internalization and Cytotoxicity of the Antimicrobial Proline-rich Peptide Bac7(1-35) in Monocytes/Macrophages, and its Activity Against Phagocytosed Salmonella Typhimurium 234
Structure dependence of biological activities for primate cathelicidins. 233
The marine toxin palytoxin induces necrotic death in HaCaT cells through a rapid mitochondrial damage 233
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 232
Synthetic antimicrobial peptides designed from sequence templates 231
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 231
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 231
Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL-37 231
Multivalent, mixed self-assembled monolayer protected gold nanoparticles: from design to biological application 229
Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852) 225
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 224
Ruthenium(III) complexes as antineoplastic agents. 223
Photobiomodulation therapy promotes in vitro wound healing in nicastrin KO HaCaT cells 223
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 221
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 220
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 217
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 217
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 217
Galectin-1 in cartilage: expression and influence on chondrocytes growth and interaction with ECM components 215
Computational and experimental investigation on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 215
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 210
Primate cathelicidin orthologues display different structures and membrane interactions 209
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 208
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity 207
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 206
Rapid and reliable detection of antimicrobial peptide penetration into Gram-negative bacteria based on fluorescence quenching. 206
Mast cell activation by myelin through scavenger receptor. 200
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 198
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 197
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 195
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 194
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts 193
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 193
Effects on APC antigen presenting cells of short-term interaction with the human human host defense peptide beta-defensin 2 193
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 192
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 190
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 190
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 190
Bacillus cereus cell and spore properties as influenced by the micro-structure of the medium 186
Fabrication of a microfluidic platform for investigating dynamic biochemical processes in living samples by FTIR microspectroscopy 185
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 184
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 184
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 183
DON'T JUDGE A BOOK BY ITS COVER: JANUS AND STRIPED SAM-PROTECTED GOLD NANOPARTICLES AT THE NANO-BIO INTERFACE 183
Biological and technological evaluation of PVC containers for human blood and blood components 182
Synchrotron radiation infrared microspectroscopy of single living cells in microfluidic devices: Advantages, disadvantages and future perspectives 181
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 180
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition 178
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma 178
Tumour metastatic potential after treatment with selective antimetastatic drugs 175
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data 174
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties 172
Lysozyme induced recovery of the response to ConA on mononuclear cells harvested from mice bearing MCa mammary carcinoma 171
Cytofluorimetric analysis of gut-intraepitelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme 171
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 171
Artificial beta-defensin based on a minimal defensin template 169
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 166
Recovery of lymphocyte CD4+:CD8+ ratio in patients treated with lysozyme 164
Structure-activity relationship study on Bac7(1-35), a synthetic fragment of the Pro-rich antibacterial peptide Bac7 162
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. 158
Modification of growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides 155
Hydrogels based on methylated-alginates as a platform to investigate the effect of material properties on cell activity. The role of material compliance 154
Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin 153
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 153
Mechanism of tumor inhibition by the metal complex trans-RuCl2(dimethylsulphoxide)4 153
Water soluble ruthenium(III)-dimethyl sulfoxide complexes: chemical behaviour and pharmacological properties 151
Infrared microspectroscopy of biochemical response of living cells in microfabricated devices 150
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections 149
Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides 147
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph nodelymphocytes of tumour bearing mice fed with egg-white lysozyme. 145
Influence of agar content on the growth parameters of Bacillus cereus. 138
Effects of the Ru(III) complexes mer-RuCl3(DMSO)2Im and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors. 138
In vitro down regulation of ICAM-1 and E-cadherin and in vivo reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative 138
Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas 135
Totale 22.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021465 0 0 0 0 0 0 0 0 0 210 69 186
2021/20221.673 56 113 123 230 32 137 80 50 172 188 108 384
2022/20232.081 210 287 161 314 188 363 7 179 215 20 78 59
2023/20241.084 97 70 73 71 108 71 163 221 22 29 91 68
2024/20253.079 49 117 196 282 276 288 272 168 390 361 304 376
2025/20267.013 705 608 801 653 647 674 1.118 244 766 797 0 0
Totale 26.089